# Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

> **NCT05936346** · NA · RECRUITING · sponsor: **IBSA Farmaceutici Italia Srl** · enrollment: 50 (estimated)

## Conditions studied

- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Salvia haenkei 175mg
- **DIETARY_SUPPLEMENT:** Salvia haenkei 350mg

## Key facts

- **NCT ID:** NCT05936346
- **Lead sponsor:** IBSA Farmaceutici Italia Srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-17
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05936346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05936346, "Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05936346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*